BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 9269249)

  • 1. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
    Zajecka J; Tracy KA; Mitchell S
    J Clin Psychiatry; 1997 Jul; 58(7):291-7. PubMed ID: 9269249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer antidepressants and the discontinuation syndrome.
    Haddad P
    J Clin Psychiatry; 1997; 58 Suppl 7():17-21; discussion 22. PubMed ID: 9219489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant discontinuation: a review of the literature.
    Lejoyeux M; Adès J
    J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.
    Schatzberg AF; Haddad P; Kaplan EM; Lejoyeux M; Rosenbaum JF; Young AH; Zajecka J
    J Clin Psychiatry; 1997; 58 Suppl 7():5-10. PubMed ID: 9219487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin reuptake inhibitor withdrawal.
    Coupland NJ; Bell CJ; Potokar JP
    J Clin Psychopharmacol; 1996 Oct; 16(5):356-62. PubMed ID: 8889907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.
    Frost L; Lal S
    Am J Psychiatry; 1995 May; 152(5):810. PubMed ID: 7726327
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
    Price JS; Waller PC; Wood SM; MacKay AV
    Br J Clin Pharmacol; 1996 Dec; 42(6):757-63. PubMed ID: 8971432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New antidepressive agents].
    LaBranche S
    Union Med Can; 1995 Nov; 124(3):8-13. PubMed ID: 8560639
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical management of antidepressant discontinuation.
    Rosenbaum JF; Zajecka J
    J Clin Psychiatry; 1997; 58 Suppl 7():37-40. PubMed ID: 9219493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delirium following abrupt discontinuation of fluoxetine.
    Blum D; Maldonado J; Meyer E; Lansberg M
    Clin Neurol Neurosurg; 2008 Jan; 110(1):69-70. PubMed ID: 17913343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential withdrawal syndrome associated with SSRI discontinuation.
    Lazowick AL; Levin GM
    Ann Pharmacother; 1995 Dec; 29(12):1284-85. PubMed ID: 8672834
    [No Abstract]   [Full Text] [Related]  

  • 13. Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient.
    Kotzalidis GD; de Pisa E; Patrizi B; Savoja V; Ruberto G; Girardi P
    J Psychopharmacol; 2008 Jul; 22(5):581-4. PubMed ID: 18208915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitor discontinuation with ECT and withdrawal symptoms.
    Markowitz JS
    J ECT; 1998 Mar; 14(1):55. PubMed ID: 9661096
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
    Preskorn SH
    J Clin Psychiatry; 1995; 56 Suppl 6():12-21. PubMed ID: 7649968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin reuptake inhibitors in Raynaud's phenomenon.
    Jaffe IA
    Lancet; 1995 May; 345(8961):1378. PubMed ID: 7752794
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.
    Black K; Shea C; Dursun S; Kutcher S
    J Psychiatry Neurosci; 2000 May; 25(3):255-61. PubMed ID: 10863885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 19. Antidepressant use during pregnancy. FPIN’s clinical inquiries.
    Patel BN; Beste J; Blackwell JC
    Am Fam Physician; 2011 May; 83(10):1211-5. PubMed ID: 21568258
    [No Abstract]   [Full Text] [Related]  

  • 20. Discontinuation symptoms and SSRIs.
    Pollock BG
    J Clin Psychiatry; 1998 Oct; 59(10):535-7. PubMed ID: 9818635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.